ArticleChemical research in toxicology2026
Prediction of Ligand Binding to Transthyretin Using Machine Learning Algorithms and Low-Dimensional Molecular Descriptors: A Tox24 Challenge Study.
Article in Chemical research in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a comprehensive machine learning approach for predicting the percent displacement of ANSA from human transthyretin (TTR) at fixed assay conditions as defined in the Tox24 Challenge. TTR is a critical serum transport protein for thyroid hormones, and its disruption by environmental chemicals can lead to endocrine system dysregulation with serious developmental and metabolic consequences. However, the scarcity of large, chemically diverse data sets and the lack of standardized experimental protocols have limited the computational prediction of TTR binding, restricting the development of robust predictive models applicable to broad chemical spaces. The described pipeline uses computationally efficient, low-dimensional (0D-2D) molecular descriptors and fingerprints. This eliminates the need for costly 3D conformational analysis. Following the systematic benchmarking of individual machine learning (ML) methods, hyperparameter optimization was performed using Optuna for two gradient boosting algorithms: CatBoost and XGBoost. The feature importance analysis revealed complementary learning strategies between these algorithms. The proposed consensus model achieved an RMSE of 21.60 on the blind test set, ranking 15th among 79 participating teams. Chemical space analysis using PCA and t-SNE confirmed that, except for two outliers, the test compounds fell within the distribution for the training set. Postchallenge analyses evaluated the effect of the cross-validation strategy (random vs cluster-based split) and descriptor dimensionality (2D-only, 3D-only, or mixed) on model performance. To facilitate broader adoption, a freely accessible web server was developed, enabling rapid toxicity prediction across multiple Tox21 and Tox24 end points without requiring computational expertise (https://toxpred.genesilico.pl/). This work demonstrates that low-dimensional molecular descriptors combined with optimized consensus ML methods can achieve competitive predictive performance, making high-throughput toxicity screening practical for drug discovery, environmental risk assessment, and regulatory decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.